Home LiteratureArticle Details
PMID: 10799651 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-stimulated Cyp1a1 promoter activity by hypoxic agents.

Biochemical pharmacology ·Vol. 59 ·No. 12 ·2000-06-15 ·Pages 1549-56

Kim JE, Sheen YY

Abstract

Since hypoxia-inducible factor-1alpha (HIF-1alpha) and the arylhydrocarbon receptor (AhR) shared the AhR nuclear translocator (Arnt) for hypoxia- and AhR-mediated signaling, respectively, it was possible to establish the hypothesis that hypoxia could regulate cytochrome P450 1a1 (Cyp1a1) expression. In order to test this hypothesis, we undertook to examine the effect of hypoxia on Cyp1a1 transcription in Hepa-I cells. Mouse Cyp1a1 5'-flanking DNA, 1.6 kb was cloned into pGL3 expression vector in order to construct pmCyp1a1-Luc. Hepa-I cells were transfected with pmCyp1a1-Luc and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the presence or absence of various hypoxic agents such as 1-100 microM cobalt chloride, 1-100 microM picolinic acid, and 1-100 microM desferrioxamine. Luciferase activity of the reporter gene was measured from pmCyp1a1-Luc-transfected Hepa-I cell lysate which contains 2 microgram total protein using luciferin as a substrate. Hypoxic agents such as cobalt chloride, picolinic acid, and desferrioxamine showed inhibition of luciferase activity that was induced by 1-nM TCDD treatment in a dose-and time-dependent manner. Concomitant treatment of 150 microM ferrous sulfate with 1-100 microM desferrioxamine or 1-100 microM picolinic acid recovered luciferase activity from that inhibited by hypoxic agents or induced by TCDD. These data demonstrated that iron-chelating and hypoxic agents inhibited dioxin-induced Cyp1a1 transcription in Hepa-I cells. Thus, we might suggest that hypoxia inhibits TCDD-induced Cyp1a1 expression due to the competition between HIF-1alpha and the AhR for the Arnt in Hepa-I cells.

MeSH Terms
Animals Antimutagenic Agents/pharmacology Cell Hypoxia Cells, Cultured Chelating Agents/pharmacology Cobalt/pharmacology Cytochrome P-450 CYP1A1/genetics,metabolism Deferoxamine/pharmacology Dose-Response Relationship, Drug Drug Interactions Ferrous Compounds/pharmacology Gene Expression Regulation, Enzymologic/drug effects Genes, Reporter Luciferases/genetics Mice Oxygen/metabolism Picolinic Acids/pharmacology Polychlorinated Dibenzodioxins/antagonists & inhibitors,pharmacology Promoter Regions, Genetic/drug effects,genetics Time Factors
Chemicals
Antimutagenic Agents Chelating Agents Ferrous Compounds Picolinic Acids Polychlorinated Dibenzodioxins ferrous sulfate Cobalt Luciferases Cytochrome P-450 CYP1A1 cobaltous chloride Deferoxamine Oxygen
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kim J E
College of Pharmacy, Ewha Womans University, # 11-1, Daehyun-dong, Sudaemun-ku, Seoul, South Korea.
Sheen Y Y
Article Info
Journal
Biochemical pharmacology
Abbr.
Biochem Pharmacol
ISSN
0006-2952
Published
2000-06-15
Pages
1549-56
Language
English
Region
England
NLM ID
0101032
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]